Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2008 Mar;19(3):339-48.
doi: 10.1007/s00198-007-0462-5. Epub 2007 Sep 11.

Bone turnover and bone collagen maturation in osteoporosis: effects of antiresorptive therapies

I Byrjalsen  1 , D J Leeming, P Qvist, C Christiansen, M A Karsdal
Affiliations
Randomized Controlled Trial

Bone turnover and bone collagen maturation in osteoporosis: effects of antiresorptive therapies

I Byrjalsen et al. Osteoporos Int. 2008 Mar.

Abstract

Bone collagen maturation may be important for anti-fracture efficacy as the reduction in risk is only partly explained by a concomitant increase in BMD during anti-resorptive therapy. Different treatments caused diverse profiles in bone collagen degradation products, which may have implications for bone quality.

Introduction: The aim of the present study was to evaluate the effect of different anti-resorptive treatments on bone collagen maturation measured as the ratio between the degradation products of newly synthesized and mature isomerized C-telopeptides of type I collagen.

Methods: Participants were from cohorts of healthy postmenopausal women participating in double blind, placebo-controlled 2-year studies of alendronate, ibandronate, intranasal hormone replacement therapy (HRT), oral HRT, transdermal HRT, or raloxifene (n = 427). The non-isomerized alphaalphaCTX and isomerized betabetaCTX were measured in urine samples obtained at baseline, and after 6, 12, and 24 months of therapy.

Results: Bone collagen maturation measured as the ratio between alphaalphaCTX and betabetaCTX showed that bisphosphonate treatment induced a collagen profile consistent with an older matrix with a 52% (alendronate) and 38% (ibandronate) reduction in the ratio between the two CTX isoforms vs. 3% and 15% with HRT or raloxifene, respectively.

Conclusions: Anti-resorptive treatments had different effects on the endogenous profile of bone collagen maturation. Whether that effect on bone collagen has an impact on bone strength independent on the treatment-dependent effect on BMD should be investigated.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Endocrinology. 2003 Dec;144(12):5441-9 - PubMed
    1. Climacteric. 2004 Mar;7(1):103-11 - PubMed
    1. J Bone Miner Res. 2004 Feb;19(2):330-7 - PubMed
    1. J Biol Chem. 1997 Apr 11;272(15):9755-63 - PubMed
    1. Bone. 1999 Mar;24(3):237-44 - PubMed

Publication types

MeSH terms

LinkOut - more resources